Evidence
Nutrients. 2023 Nov 25;15(23):4917. doi: 10.3390/nu15234917.
ABSTRACT
Non-alcoholic fatty liver disease (NAFLD) is one of the leading causes of chronic liver disease and represents a public health issue in Western industrialized countries […].
PMID:38068775 | DOI:10.3390/nu15234917
Add to Google Keep
Estimated reading time: 1 minute(s)
Latest: Psychiatryai.com #RAISR4D
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
New Insights into Nutrition and Gut-Liver Axis: A Focus on Non-Alcoholic Fatty Liver Disease
🌐 90 Days
VR Related Evidence Matrix
- Beneficial Effects of Dietary Flaxseed on Non-Alcoholic Fatty Liver Disease
- What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
- What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
- The Impact of Probiotic Bifidobacterium on Liver Diseases and the Microbiota
- Investigating the Role of Non-Coding RNA in Non-Alcoholic Fatty Liver Disease
- The role of Sirtuin 2 in liver - An extensive and complex biological process
- Research progress in the regulation of pathogenesis and the transformation of chronic liver disease by short-chain fatty acids
- Immunology of gut microbiome and liver in non-alcoholic fatty liver disease (NAFLD): mechanisms, bacteria, and novel therapeutic targets
- Diabetes Mellitus among Patients with Non-alcoholic Fatty Liver Disease Visiting the Outpatient Department of Internal Medicine in a Tertiary Care Centre
- Occult liver disease: a multinational perspective
- Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease
- Muscle strength and non-alcoholic fatty liver disease/metabolic-associated fatty liver disease
- Iron metabolism and ferroptosis in Non-alcoholic fatty liver disease: what is our next step?
- Interaction between Per- and Polyfluorinated Substances (PFAS) and Acetaminophen in Disease Exacerbation-Focusing on Autism and the Gut-Liver-Brain Axis
- Gut Microbiota in Patients with Non-Alcoholic Fatty Liver Disease without Type 2 Diabetes: Stratified by Body Mass Index
- Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies
- Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
- Transient Elastography Is the Best-Performing Non-Invasive Test of Liver Fibrosis in Obese Asian Patients with Non-Alcoholic Fatty Liver Disease: A Pilot, Cross-Sectional Study
- Chronic liver disease and management with silymarin: an introductory review of a clinical case collection
- Fecal microbiota transplantation for treatment of non-alcoholic fatty liver disease: Mechanism, clinical evidence, and prospect
- Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics
- A Review: Cytochrome P450 in Alcoholic and Non-Alcoholic Fatty Liver Disease
- MASLD: a systemic metabolic disorder with cardiovascular and malignant complications
- Exploring the interplay of gut microbiota, inflammation, and LDL-cholesterol: a multiomics Mendelian randomization analysis of their causal relationship in acute pancreatitis and non-alcoholic fatty liver disease
- Ultrasonographic findings of metabolic dysfunction-associated fatty liver disease: A comparative study with non-alcoholic fatty liver disease and clinical characteristics
- Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice
- Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12
- Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12
- Polysaccharide from Panax japonicus C.A. Mey prevents non-alcoholic fatty liver disease development based on regulating liver metabolism and gut microbiota in mice
- Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies
- Bacteroides fragilis aggravates high-fat diet-induced non-alcoholic fatty liver disease by regulating lipid metabolism and remodeling gut microbiota
- Serine protease inhibitor from the muscle larval Trichinella spiralis ameliorates non-alcoholic fatty liver disease in mice via anti-inflammatory properties and gut-liver crosstalk
- Non-alcoholic fatty liver disease promotes liver metastasis of colorectal cancer via fatty acid synthase dependent EGFR palmitoylation
- SHMT2 reduces fatty liver but is necessary for liver inflammation and fibrosis in mice
- SHMT2 reduces fatty liver but is necessary for liver inflammation and fibrosis in mice
- Epidemiological characteristics of inpatients with liver failure at the Beijing You'an Hospital from 2012 to 2021
- Research progress on the mechanism of action of heme oxygenase-1 regulating ferroptosis in non-alcoholic fatty liver disease
- Comparison of size of the liver between patients with non-alcoholic fatty liver disease and healthy controls
- Patients undergoing liver resection for non-alcoholic fatty liver disease-related hepatocellular carcinoma and those for viral hepatitis-related hepatocellular carcinoma have similar survival outcomes
- Dysregulation of RNA splicing in early non-alcoholic fatty liver disease through hepatocellular carcinoma
- Enhanced non-alcoholic fatty liver detection: Computed tomography scan image analysis and noise reduction with morphological dilation
- Increased Risk of Colorectal Adenomas with Metabolic-Associated Fatty Liver Disease Components
- Role of the angiopoietin-like protein family in the progression of NAFLD
- Increasing the efficiency of hypolipidemic therapy with the combined use of quercetin in patients with non-alcoholic fatty liver disease on the background of the metabolic syndrome
- Mass spectrometry imaging-based metabolomics highlights spatial metabolic alterations in three types of liver injuries
- Cyanidin-3-O-Glucoside Alleviates Alcoholic Liver Injury via Modulating Gut Microbiota and Metabolites in Mice
- Vitamin K2 protects mice against non-alcoholic fatty liver disease induced by high-fat diet
- Metabolic study of iron deposition based on magnetic resonance in patients with nonalcoholic fatty liver disease
- Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study
- The effects of replacing ghee with rapeseed oil on liver steatosis and enzymes, lipid profile, insulin resistance, and anthropometric measurements in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial
- Impact of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) on the expression and function of hepatobiliary transporters: A comprehensive mechanistic review
- Understanding the role of ursodeoxycholic acid and gut microbiome in non-alcoholic fatty liver disease: current evidence and perspectives
- Atorvastatin on Treatment of Nonalcoholic Fatty Liver Disease Patients
- COVID-19 in Individuals with Chronic Liver Diseases
- Puerarin protects the fatty liver from ischemia-reperfusion injury by regulating the PI3K/AKT signaling pathway
- Targeted platelet with hydrogen peroxide responsive behavior for non-alcoholic steatohepatitis detection
- Immunomodulation in non-alcoholic fatty liver disease: exploring mechanisms and applications
- Liver Lipidomics Analysis Revealed the Protective mechanism of Zuogui Jiangtang Qinggan Formula in type 2 diabetes mellitus with non-alcoholic fatty liver disease
- Liver Lipidomics Analysis Revealed the Protective mechanism of Zuogui Jiangtang Qinggan Formula in type 2 diabetes mellitus with non-alcoholic fatty liver disease
- Autophagy and the unfolded protein response shape the non-alcoholic fatty liver landscape: decoding the labyrinth
- Gender-Specific Bile Acid Profiles in Non-Alcoholic Fatty Liver Disease
- Association between dietary vitamin A intake from different sources and non-alcoholic fatty liver disease among adults
- The double roles of T cell-mediated immune response in the progression of MASLD
- Inflammatory liver diseases and susceptibility to sepsis
Evidence Blueprint
New Insights into Nutrition and Gut-Liver Axis: A Focus on Non-Alcoholic Fatty Liver Disease
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
New Insights into Nutrition and Gut-Liver Axis: A Focus on Non-Alcoholic Fatty Liver Disease
🌐 365 Days
VR Related Evidence Matrix
- Effect of the nomenclature of non-alcoholic fatty liver disease on diagnosis and treatment of fatty liver disease concomitant with other liver diseases
- Adlercreutzia equolifaciens Is an Anti-Inflammatory Commensal Bacterium with Decreased Abundance in Gut Microbiota of Patients with Metabolic Liver Disease
- Sex, Nutrition, and NAFLD: Relevance of Environmental Pollution
- Myokines: Crosstalk and Consequences on Liver Physiopathology
- Detection and Quantification of Some Ethanol-Producing Bacterial Strains in the Gut of Mouse Model of Non-Alcoholic Fatty Liver Disease: Role of Metformin
- Gut Microbiota and Plasma Bile Acids Associated with Non-Alcoholic Fatty Liver Disease Resolution in Bariatric Surgery Patients
- Non-alcoholic fatty liver disease and periodontal disease: A systematic review and meta-analysis of cross-sectional studies
- Beneficial Effects of Dietary Flaxseed on Non-Alcoholic Fatty Liver Disease
- The Association between Liver Enzymes and Mortality Stratified by Non-Alcoholic Fatty Liver Disease: An Analysis of NHANES III
- Type 2 Diabetes Mellitus and Liver Disease: Across the Gut-Liver Axis from Fibrosis to Cancer
- What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
- What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
- Anti-Angiogenic Effects of Natural Compounds in Diet-Associated Hepatic Inflammation
- Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease
- SGLT-2 Inhibitors for Non-Alcoholic Fatty Liver Disease: A Review
- The Impact of Probiotic Bifidobacterium on Liver Diseases and the Microbiota
- Type 2 Diabetes Mellitus, Non-Alcoholic Fatty Liver Disease, and Metabolic Repercussions: The Vicious Cycle and Its Interplay with Inflammation
- From Non-Alcoholic Fatty Liver Disease to Liver Cancer: Microbiota and Inflammation as Key Players
- Highland barley β-glucan supplementation attenuated hepatic lipid accumulation in Western diet-induced non-alcoholic fatty liver disease mice by modulating gut microbiota
- Molecular Mechanism Pathways of Natural Compounds for the Treatment of Non-Alcoholic Fatty Liver Disease
- Expanding Pharmacists' Role in the Management of Non-Alcoholic Fatty Liver Disease
- Investigating the Role of Non-Coding RNA in Non-Alcoholic Fatty Liver Disease
- The role of Sirtuin 2 in liver - An extensive and complex biological process
- The significance of omega-3 fatty acids in the treatment of non-alcoholic fatty liver disease
- Association between the gut microbiota and nonalcoholic fatty liver disease: A two-sample Mendelian randomization study
- Impact of Porphyromonas gingivalis-odontogenic infection on the pathogenesis of non-alcoholic fatty liver disease
- The Role of Fucoxanthin in Non-Alcoholic Fatty Liver Disease
- The Role of Vitamin D in Obese Children with Non-Alcoholic Fatty Liver Disease and Associated Metabolic Syndrome
- Research progress in the regulation of pathogenesis and the transformation of chronic liver disease by short-chain fatty acids
- Impacts of gut microbiota alteration on age-related chronic liver diseases
- Akkermansia muciniphila - a Potential Next-generation Probiotic for Non-alcoholic Fatty Liver Disease
- Immunology of gut microbiome and liver in non-alcoholic fatty liver disease (NAFLD): mechanisms, bacteria, and novel therapeutic targets
- Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy
- Alcoholic liver disease - 2023
- Diabetes Mellitus among Patients with Non-alcoholic Fatty Liver Disease Visiting the Outpatient Department of Internal Medicine in a Tertiary Care Centre
- Innate Immune System in the Pathogenesis of Non-Alcoholic Fatty Liver Disease
- A High-Fat Diet Increases the Characteristics of Gut Microbial Composition and the Intestinal Damage Associated with Non-Alcoholic Fatty Liver Disease
- Serum Ferritin and Non-alcoholic Fatty Liver Disease: A Meta-analysis and Systematic Review
- Occult liver disease: a multinational perspective
- Impact of Chronotype and Mediterranean Diet on the Risk of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
- Diabetes and fatty liver: Involvement of incretin and its benefit for fatty liver management
- Gut Microbiota Patterns in Patients with Non-Alcoholic Fatty Liver Disease: A Comprehensive Assessment Using Three Analysis Methods
- Hormone action and liver disease, a complex interplay
- How to identify at-risk NAFLD in the primary care setting
- Fatty liver disease's renaming impacts on drug clinical trials
- Metabolic dysfunction: The silenced connection with fatty liver disease
- From complement to complosome in non-alcoholic fatty liver disease: When location matters
- Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease
- Corrected and republished from: Metabolic associated liver disease
- Liver Fat Storage Is a Better Predictor of Coronary Artery Disease than Visceral Fat
- Bioinformatics analysis and machine learning approach applied to the identification of novel key genes involved in non-alcoholic fatty liver disease
- The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence
- Research progress on the histological scoring system for nonalcoholic fatty liver disease
- Muscle strength and non-alcoholic fatty liver disease/metabolic-associated fatty liver disease
- Differences in Fecal Short-Chain Fatty Acids between Alcoholic Fatty Liver-Induced Cirrhosis and Non-alcoholic (Metabolic-Associated) Fatty Liver-Induced Cirrhosis
- Comprehensive analysis of epigenetic and epitranscriptomic genes' expression in human NAFLD
- Association of 24 h Behavior Rhythm with Non-Alcoholic Fatty Liver Disease among American Adults with Overweight/Obesity
- Diet and non-alcoholic fatty liver disease, a short narrative review
- Effects of Royal Jelly on Gut Dysbiosis and NAFLD in db/db Mice
- Role of Hepatic Aryl Hydrocarbon Receptor in Non-Alcoholic Fatty Liver Disease
- Identification and validation of cuproptosis-related molecular clusters in non-alcoholic fatty liver disease
- Vitamin D/Vitamin D receptor pathway in nonalcoholic fatty liver disease
- Iron metabolism and ferroptosis in Non-alcoholic fatty liver disease: what is our next step?
- Gut microbiota metabolite TMAO promoted lipid deposition and fibrosis process via KRT17 in fatty liver cells in vitro